TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma.

Elizabeth L McMichael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.